Camp4 Therapeutics (CAMP) Accounts Payables (2023 - 2026)

Camp4 Therapeutics has disclosed Accounts Payables across 4 years of filings, most recently posting $863000.0 for Q1 2026.

• Accounts Payables for Q1 2026 came in at $863000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $863000.0 (changed N/A YoY), and the FY2025 annual result was $182000.0, down 84.96% from the prior year.
• Accounts Payables came in at $863000.0 for Q1 2026 at Camp4 Therapeutics, up from $182000.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $3.9 million in Q3 2024 to a low of $182000.0 in Q4 2025.
• The 4-year median for Accounts Payables is $1.0 million (2023), against an average of $1.3 million.
• Across the five-year window, Accounts Payables gained 16.12% in 2024 and tumbled 84.96% in 2025, its largest moves.
• Camp4 Therapeutics' Accounts Payables stood at $1.0 million in 2023, then rose by 16.12% to $1.2 million in 2024, then sank by 84.96% to $182000.0 in 2025, then surged by 374.18% to $863000.0 in 2026.
• The last three Accounts Payables figures came in at $863000.0 (Q1 2026), $182000.0 (Q4 2025), and $585000.0 (Q3 2025), per Business Quant data.